Health Condition 1: O- Medical and Surgical Health Condition 2: M21- Other acquired deformities of limbs
Conditions
Interventions
Intervention1: effect of sugammadex as a neuromuscular block reversal drug on postoperative cognitive dysfunction in
older adults undergoing hip surgeries: effect of sugammadex as a neuromuscular bloc
Sponsors
Shreya Chauhan
Eligibility
Inclusion criteria
Inclusion criteria: Posted for elective hip surgeries under general anesthesia with ASA Physical Status one two three
Exclusion criteria
Exclusion criteria: Any neurological disorder affecting the patients ability to understand the questionnaire Patients with such visual or hearing impairment that it affects the patients ability to read the scale or answer the questions that will be asked Patients taking antidepressants and or tranquilisers Any known allergies to drug being administered Patient refusal
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the cognitive function using Postoperative Quality of Recovery Scale PQRS at 30min 12hrs 24hrs 72hrs 7th day and 30th day postoperatively from baseline values in patients receiving Sugammadex vs those receiving neostigmine plus glycopyrrolate combinationTimepoint: To compare the cognitive function using Postoperative Quality of Recovery Scale PQRS at 30min 12hrs 24hrs 72hrs 7th day and 30th day postoperatively | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess the hemodynamic adverse effects of sugammadex that is bradycardia and hypotension within 30 mins of its administration. To assess the total intraoperative opioid consumption. To assess the postoperative electrolytes levels within 24hrs.Timepoint: observe for bradycardia after 30 mins of reversal administration observe electrolytes after 24hrs | — |
Countries
India
Contacts
Public ContactDr Shagufta Naaz
AIIMS Patna
Outcome results
None listed